Back

External validation of models predicting heart failure in haematological malignancies

19 June 2026 (11:45 - 12:45)
Organised by: Logo
Congress Presentation Part of: Stratifying the risk of cardiotoxicity (1) Stratification, Prevention and Monitoring Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mr Jesse Geels

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Risk of post-transplant cyclophosphamide-related cardiotoxicity in allogeneic stem cell transplantation
Doctor T. Goncalves (Toronto, CA)
Abstract Slides
Presentation thumbnail
Left atrioventricular coupling index: a novel predictor of cardiovascular adverse events during cardiotoxic therapy in multiple myeloma patients
Professor A. Milan (Turin, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of high-sensitivity Troponin I vs T in metastatic melanoma patients with immune checkpoint inhibitor-related low-risk myocarditis
Doctor V. Rossi (Zurich, CH)
Abstract Slides
Presentation thumbnail
Baseline lipoprotein(a) and heart failure-related events in oncology patients: competing-risk analysis
Assistant Professor A. Campos Staffico (Omaha, US)
Abstract Slides
Presentation thumbnail
Baseline cardiovascular and cardiotoxicity risk in newly diagnosed breast cancer: insights from a nationwide turkish registry (CARPE DIEM-TR)
Doctor Y. Sener (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Stratifying the risk of cardiotoxicity (1)

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 11:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources